Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers
- 1 May 1993
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 35 (1) , 67-82
- https://doi.org/10.1002/jnr.490350109
Abstract
Iron has recently been suggested to contribute to the pathogenesis of Parkinson's disease (PD) because of the finding of increased iron levels in the substantia nigra pars compacta (SNc) above those of control patients. Iron is capable of catalyzing numerous reactions which could lead to free radical formation and oxidative damage to DNA, proteins, lipid membranes, and other biological molecules. Neurodegeneration in the SNc of the PD brain may be a consequence of increased iron, which promotes these cytotoxic reactions. To test whether excess iron could play a causative role in the degeneration of nigral neurons, we infused 1.25–6.3 mnol of iron into the rat substantia nigra (SN) unilaterally utilizing two different infusion protocols. All infusates were isosmotic and pH-balanced in a citrate-bicarbonate vehicle. Animals were decapitated at either 1 or 2 months postinfusion. Striatal tissue was assayed for biogenic amines by HPLC and the remaining brainstem was processed for histological analysis. Ironstained coronal sections revealed (1) no left/right staining difference with vehicle infusion, (2) a dose-dependent iron accumulation in the infused SN that was restricted to the zona compacta and dorsal-most zona reticularis when the lowest iron concentration was infused, and (3) a dose-dependent reduction in SN volume. Thionine-stained sections revealed neuronal loss and accompanying reactive gliosis within an area that corresponded closely to that of increased iron staining. These degenerative changes were more extensive in animals infused via a side-by side vs. a sequential protocol. Neurochemically, there was a highly significant correlation between the amount of iron infused intranigrally and magnitude of reductions in striatal DA, DOPAC, and HVA within the ipsilateral striatum. These data indicate that iron infusion into the SN can cause degenerative changes within the SN and that these changes can be restricted to the SNc region when low amounts of iron are infused. The data further support the hypothesis that iron-induced degeneration may contribute to the pathogenesis of PD.Keywords
This publication has 47 references indexed in Scilit:
- Iron in Brain Function and Dysfunction with Emphasis on Parkinson’s DiseaseEuropean Neurology, 1991
- Superoxide dismutase and cytochrome oxidase activities in light and heavy synaptic mitochondria from rat cerebral cortex during agingJournal of Neuroscience Research, 1989
- Oxyferriscorbone elevates the total iron content of blood but not brainMovement Disorders, 1989
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamineBiochemical and Biophysical Research Communications, 1988
- Oxidation of ferrous iron during peroxidation of lipid substratesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987
- Studies on the effect of iron overload on rat cortex synaptosomal membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metalsBiochemical and Biophysical Research Communications, 1985
- The role of superoxide and hydroxyl radicals in phospholipid peroxidation catalysed by iron saltsFEBS Letters, 1982
- Chronic Focal Epileptiform Discharges Induced by Injection of Iron Into Rat and Cat CortexScience, 1978